Oragenics
Country
USA
Краткое название
Oragenics
Headquarters
4902 Eisenhower Boulevard Suite 125
Members of the board
John N Bonfiglio,President/CEO
Michael O Sullivan Mike Chief, Financial Officer
Martin Handfield,VP:Research & Dev
Categories medicine
Stomatology
Stage of the project
Production
Disease
Periodontosis, Dental caries
Ticker
OGEN
Assets
55.6600
Technology
Devices, Technologies, Pharmaceuticals, Chemistry